These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18496721)

  • 41. European union regulation of health technology assessment: what is required for it to succeed?
    Drummond M; Tarricone R; Torbica A
    Eur J Health Econ; 2022 Aug; 23(6):913-915. PubMed ID: 35348920
    [No Abstract]   [Full Text] [Related]  

  • 42. The examining room--technology assessment: the fallibility factor.
    Felch WC
    Internist; 1979 Sep; 20(7):11,16. PubMed ID: 10243878
    [No Abstract]   [Full Text] [Related]  

  • 43. Selecting new technologies and equipment: a decision-making process.
    Dykstra B
    Dent Today; 2007 Jan; 26(1):118, 120-1. PubMed ID: 17278607
    [No Abstract]   [Full Text] [Related]  

  • 44. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.
    Hartz S; John J
    Int J Technol Assess Health Care; 2008; 24(4):465-72. PubMed ID: 18828942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
    Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiation oncology health technology assessment: the best is the enemy of the good.
    Bentzen SM
    Nat Clin Pract Oncol; 2008 Oct; 5(10):563. PubMed ID: 18818689
    [No Abstract]   [Full Text] [Related]  

  • 48. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonography.
    Husereau D; Morrison A; Battista R; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):343-52. PubMed ID: 19394575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health technology assessment for radiologists: basic principles and evaluation framework.
    Lim ME; O'Reilly D; Tarride JE; Burke N; Ferrusi IL; Campbell K; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):299-306. PubMed ID: 19394570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment.
    Kinter ET; Schmeding A; Rudolph I; dosReis S; Bridges JF
    Int J Technol Assess Health Care; 2009 Jan; 25(1):35-41. PubMed ID: 19126249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wise buys.
    Freemantle N
    Health Serv J; 1992 Jan; 102(5285):23. PubMed ID: 10116994
    [No Abstract]   [Full Text] [Related]  

  • 54. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health technology assessment and public health: a time for convergence.
    Battista RN; Lafortune L
    Eur J Public Health; 2009 Jun; 19(3):227. PubMed ID: 19380330
    [No Abstract]   [Full Text] [Related]  

  • 56. Coverage with evidence development: merit for motherhood?
    Koch P
    Int J Technol Assess Health Care; 2011 Oct; 27(4):322; author reply 322-3. PubMed ID: 21936971
    [No Abstract]   [Full Text] [Related]  

  • 57. Health technology assessment programme.
    J Med Screen; 2008; 15(1):52-4. PubMed ID: 18416961
    [No Abstract]   [Full Text] [Related]  

  • 58. Why it's Time to Abandon the ICER.
    Paulden M
    Pharmacoeconomics; 2020 Aug; 38(8):781-784. PubMed ID: 32390066
    [No Abstract]   [Full Text] [Related]  

  • 59. Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy.
    Migliore A; Ratti M; Cerbo M; Jefferson T
    Expert Rev Med Devices; 2009 May; 6(3):251-7. PubMed ID: 19419283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Worlds apart? Healthcare technologies for lifelong disease management.
    Parsloe C
    IEEE Eng Med Biol Mag; 2003; 22(1):53-6. PubMed ID: 12683063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.